Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9058 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8819 |
High Similarity |
NPD7390 |
Discontinued |
0.8378 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8252 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8235 |
Intermediate Similarity |
NPD1201 |
Approved |
0.8217 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8165 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8138 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8138 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8125 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8112 |
Intermediate Similarity |
NPD943 |
Approved |
0.8112 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8095 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8082 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8082 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8082 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8082 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7961 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7949 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7949 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7799 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7756 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7682 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7673 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7625 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7622 |
Intermediate Similarity |
NPD1164 |
Approved |
0.761 |
Intermediate Similarity |
NPD2801 |
Approved |
0.758 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7562 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7484 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7483 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7469 |
Intermediate Similarity |
NPD3749 |
Approved |
0.741 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7317 |
Intermediate Similarity |
NPD919 |
Approved |
0.731 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7303 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7294 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7256 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD920 |
Approved |
0.7219 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7209 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7203 |
Intermediate Similarity |
NPD2932 |
Approved |
0.719 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7133 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7091 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7078 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD7054 |
Approved |
0.707 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7041 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2309 |
Approved |
0.702 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7011 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7 |
Intermediate Similarity |
NPD6535 |
Approved |
0.6995 |
Remote Similarity |
NPD6780 |
Approved |
0.6995 |
Remote Similarity |
NPD6777 |
Approved |
0.6995 |
Remote Similarity |
NPD6779 |
Approved |
0.6995 |
Remote Similarity |
NPD6778 |
Approved |
0.6995 |
Remote Similarity |
NPD6782 |
Approved |
0.6995 |
Remote Similarity |
NPD6781 |
Approved |
0.6995 |
Remote Similarity |
NPD6776 |
Approved |
0.698 |
Remote Similarity |
NPD2798 |
Approved |
0.6973 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6939 |
Remote Similarity |
NPD3972 |
Approved |
0.6933 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6913 |
Remote Similarity |
NPD1203 |
Approved |
0.6909 |
Remote Similarity |
NPD37 |
Approved |
0.6908 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6885 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6885 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD2342 |
Discontinued |
0.6882 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD7698 |
Approved |
0.6882 |
Remote Similarity |
NPD7697 |
Approved |
0.6882 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6879 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD7635 |
Approved |
0.6878 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6855 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6849 |
Remote Similarity |
NPD4626 |
Approved |
0.6845 |
Remote Similarity |
NPD8319 |
Approved |
0.6845 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6835 |
Remote Similarity |
NPD74 |
Approved |
0.6835 |
Remote Similarity |
NPD9266 |
Approved |
0.6828 |
Remote Similarity |
NPD9545 |
Approved |
0.6818 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6815 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6813 |
Remote Similarity |
NPD6190 |
Approved |
0.6811 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6797 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD411 |
Approved |
0.6792 |
Remote Similarity |
NPD2654 |
Approved |
0.679 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6786 |
Remote Similarity |
NPD4965 |
Approved |
0.6786 |
Remote Similarity |
NPD4966 |
Approved |
0.678 |
Remote Similarity |
NPD8313 |
Approved |
0.678 |
Remote Similarity |
NPD8312 |
Approved |
0.6779 |
Remote Similarity |
NPD4749 |
Approved |
0.6765 |
Remote Similarity |
NPD846 |
Approved |
0.6765 |
Remote Similarity |
NPD940 |
Approved |
0.6763 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6763 |
Remote Similarity |
NPD9267 |
Approved |
0.6763 |
Remote Similarity |
NPD9264 |
Approved |
0.6763 |
Remote Similarity |
NPD9263 |
Approved |
0.6757 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6755 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6754 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6754 |
Remote Similarity |
NPD7874 |
Approved |
0.6752 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6744 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6737 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6733 |
Remote Similarity |
NPD1876 |
Approved |
0.6726 |
Remote Similarity |
NPD4288 |
Approved |
0.6724 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6723 |
Remote Similarity |
NPD4955 |
Approved |
0.6723 |
Remote Similarity |
NPD4954 |
Approved |
0.6723 |
Remote Similarity |
NPD5028 |
Approved |
0.6723 |
Remote Similarity |
NPD5026 |
Approved |
0.6723 |
Remote Similarity |
NPD5034 |
Approved |
0.6723 |
Remote Similarity |
NPD36 |
Approved |
0.6721 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6721 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6711
|
Remote Similarity |
NPD1608 |
Approved |